tirzepatide inline FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Most Successful Weight Loss Program. Switch to Tirzepatide in T2D

Set the vial down

Gastrointestinal effects The most commonly reported GI side effects are nausea and decreased appetite

Special Warnings and Precautions for Use of Mounjaro: Gastrointestinal Effects The use of GIP/GLP-1 receptor agonist weight loss injections may be associated with gastrointestinal adverse reactions that can cause dehydration, which in rare cases can lead to a deterioration of renal function

Hair loss Rapid weight loss from any cause can trigger temporary hair shedding, a condition called telogen effluvium

10.1136/bmj.l4898 60 TaheriS.SaffaeiA.AmaniB.AkbarzadehA.PeiravianF.YousefiN

As hunger becomes easier to manage, daily calorie intake decreases without the need for extreme restriction